XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues, net:    
Revenue $ 80,285,000 $ 54,467,000
Costs of sales:    
Cost of sales 59,672,000 44,267,000
Gross margin 20,613,000 10,200,000
Operating expenses:    
Selling, general and administrative 22,368,000 14,537,000
Research and development 10,841,000 5,809,000
Amortization of identifiable intangible assets 213,000 275,000
Gain on insurance proceeds 0 (4,400,000)
Operating expenses 33,422,000 16,221,000
Operating loss (12,809,000) (6,021,000)
Other expense, net (368,000) (51,000)
Interest expense, net (2,463,000) (2,160,000)
Loss before provision for income taxes (15,640,000) (8,232,000)
Provision for income taxes (10,000) (39,000)
Net loss $ (15,650,000) $ (8,271,000)
Net loss per share, basic (in dollars per share) $ (0.58) $ (0.38)
Net loss per share, diluted (in dollars per share) $ (0.58) $ (0.38)
Weighted average shares outstanding, basic (in shares) 26,970 21,929
Weighted average shares outstanding, diluted (in shares) 26,970 21,929
Product    
Revenues, net:    
Revenue $ 25,073,000 $ 18,556,000
Costs of sales:    
Cost of sales 19,997,000 14,885,000
Service    
Revenues, net:    
Revenue 33,773,000 18,028,000
Costs of sales:    
Cost of sales 19,796,000 12,695,000
Contract    
Revenues, net:    
Revenue 21,439,000 17,883,000
Costs of sales:    
Cost of sales $ 19,879,000 $ 16,687,000